Apolipoprotein A-I

Updated: July 1, 2024

Mail Whatsapp PDF Image


Background

Apolipoprotein A-I or Apo-A1 is a functional and structural protein. It constitutes 70% of the HDL protein. This protein is produced in the intestines and liver. In peripheral tissues, it activates the LCAT (lecithin-cholesterol acyltransferase). It transfers the free cholesterol to the cholesterol ester. For the degradation, it facilitates the transportation to liver.

Indications/Applications

It is unclear to use Apo-A1 as an independent indicator for cardiovascular disease. It is helpful to measure Apo-A1 with Apo-B to determine the Apo-B/Apo-A1 ratio.

A high ratio indicates a high risk of cholesterol buildup in the arteries. It leads to atherosclerosis and cardiovascular disease.

As per the study of Xiao et al., the ratio of Apo-B/Apo-A1 is significantly associated with the abdominal aortic aneurysm (AAA) compared to the coronary heart disease (CHD). Apo-A1 has been found more protective to the AAA disease than the CHD.

As per the study of Henson et al., patients who have coronary artery disease, decreased level of immune complex Aop-A1 and IgG are distinct cause for adverse cardiovascular disease. So, as per the researchers, immune complex may be used as a potential biomarker to determine the progression of cardiovascular disease.

Apo-A1 is the blood biomarker which is used in the fibroTest. This test is a non-invasive test of the liver that has been validated for many liver diseases like hepatitis B, hepatitis C, Alcoholic liver disease, and non-alcoholic fatty liver disease.

Clinical Significance:

Serum apo-A1 test is not suggested as a routine test for cardiovascular disorder risk assessment.

Apo-A1 has a naturally existing mutant known as Apo-A1 Milano. It is linked to a very low HDL level but long lifespan and less atherosclerosis than predicated HDL-C level.

A mutation in Apo-A1 gene can lead to deficiency in HDL and systemic non-neuropathic amyloidosis.

Reference Range

The normal level of Apo-A1 in adult:

Men: 75 to 160 mg/dL

Women: 80 to 175 mg/dL

The normal level of Apo-A1 in newborns:

Men: 41 to 93 mg/dL

Women: 38 to 106 mg/dL

The normal level of Apo-A1 in men whose age is between 6 months to 4 years: 67 to 167 mg/dL

The normal level of Apo-A1 in women whose age is between 6 months to 4 years: 60 to 148 mg/dL

The normal level of Apo-A1 in children whose age is 5 to 17 years: 83 to 151 mg/dL

Interpretation

Low level of Apo- A1 leads to the high risk of cardiovascular disease and, importantly in, the increased level of Apo-B.

Conditions which are associated with the decreased level of Apo-A1 are like:

Chronic kidney disease

Chronic liver disease

Smoking

High level of triglyceride

Obesity

Familial hypoalphalipoproteinaemia or Tangier disease

Uncontrolled diabetes

Coronary artery disease

Conditions which are associated with the increased level of Apo-A1 are like:

Alcohol use

Pregnancy

Familial hyperalphalipoproteinaemia

Summer and spring seasons

cholesteryl ester transfer protein deficiency (CETP)

Collection And Panels

Sample type: Serum

Sample collection container: Lavender top (EDTA)

Unacceptable samples: Hemolyzed samples

Sample preparation: Serum is separated from the blood within 2 hours or as soon as possible after the blood collection. Seum is transfer in to 1 ml serum separator tube.

Storage or transport instructions: Refrigerated samples

Samples stability: Samples can be stored for 8 days in unfrozen condition and 3 months in frozen condition.

Considerations: Overnight fasting is not required but many laboratory still suggest for 12 to 14 hours of overnight fasting.

Panels: This test is not part of any panels or not included any other test.

Modifying factors: Some medications like androgens, diuretics, beta-blockers, progestins, and androgens may decrease the level of Apo-A1. Some medications like carbamazepine, phenytoin, estrogens, fibrates, lovastatin, ethanol, niacin, phenobarbital, oral contraceptives, simvastatin, and pravastatin may increase the level of Apo-A1.

References

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721368/

Content loading

Apolipoprotein A-I


Apolipoprotein A-I or Apo-A1 is a functional and structural protein. It constitutes 70% of the HDL protein. This protein is produced in the intestines and liver. In peripheral tissues, it activates the LCAT (lecithin-cholesterol acyltransferase). It transfers the free cholesterol to the cholesterol ester. For the degradation, it facilitates the transportation to liver.

It is unclear to use Apo-A1 as an independent indicator for cardiovascular disease. It is helpful to measure Apo-A1 with Apo-B to determine the Apo-B/Apo-A1 ratio.

A high ratio indicates a high risk of cholesterol buildup in the arteries. It leads to atherosclerosis and cardiovascular disease.

As per the study of Xiao et al., the ratio of Apo-B/Apo-A1 is significantly associated with the abdominal aortic aneurysm (AAA) compared to the coronary heart disease (CHD). Apo-A1 has been found more protective to the AAA disease than the CHD.

As per the study of Henson et al., patients who have coronary artery disease, decreased level of immune complex Aop-A1 and IgG are distinct cause for adverse cardiovascular disease. So, as per the researchers, immune complex may be used as a potential biomarker to determine the progression of cardiovascular disease.

Apo-A1 is the blood biomarker which is used in the fibroTest. This test is a non-invasive test of the liver that has been validated for many liver diseases like hepatitis B, hepatitis C, Alcoholic liver disease, and non-alcoholic fatty liver disease.

Clinical Significance:

Serum apo-A1 test is not suggested as a routine test for cardiovascular disorder risk assessment.

Apo-A1 has a naturally existing mutant known as Apo-A1 Milano. It is linked to a very low HDL level but long lifespan and less atherosclerosis than predicated HDL-C level.

A mutation in Apo-A1 gene can lead to deficiency in HDL and systemic non-neuropathic amyloidosis.

The normal level of Apo-A1 in adult:

Men: 75 to 160 mg/dL

Women: 80 to 175 mg/dL

The normal level of Apo-A1 in newborns:

Men: 41 to 93 mg/dL

Women: 38 to 106 mg/dL

The normal level of Apo-A1 in men whose age is between 6 months to 4 years: 67 to 167 mg/dL

The normal level of Apo-A1 in women whose age is between 6 months to 4 years: 60 to 148 mg/dL

The normal level of Apo-A1 in children whose age is 5 to 17 years: 83 to 151 mg/dL

Low level of Apo- A1 leads to the high risk of cardiovascular disease and, importantly in, the increased level of Apo-B.

Conditions which are associated with the decreased level of Apo-A1 are like:

Chronic kidney disease

Chronic liver disease

Smoking

High level of triglyceride

Obesity

Familial hypoalphalipoproteinaemia or Tangier disease

Uncontrolled diabetes

Coronary artery disease

Conditions which are associated with the increased level of Apo-A1 are like:

Alcohol use

Pregnancy

Familial hyperalphalipoproteinaemia

Summer and spring seasons

cholesteryl ester transfer protein deficiency (CETP)

Sample type: Serum

Sample collection container: Lavender top (EDTA)

Unacceptable samples: Hemolyzed samples

Sample preparation: Serum is separated from the blood within 2 hours or as soon as possible after the blood collection. Seum is transfer in to 1 ml serum separator tube.

Storage or transport instructions: Refrigerated samples

Samples stability: Samples can be stored for 8 days in unfrozen condition and 3 months in frozen condition.

Considerations: Overnight fasting is not required but many laboratory still suggest for 12 to 14 hours of overnight fasting.

Panels: This test is not part of any panels or not included any other test.

Modifying factors: Some medications like androgens, diuretics, beta-blockers, progestins, and androgens may decrease the level of Apo-A1. Some medications like carbamazepine, phenytoin, estrogens, fibrates, lovastatin, ethanol, niacin, phenobarbital, oral contraceptives, simvastatin, and pravastatin may increase the level of Apo-A1.

Free CME credits

Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.

Digital Certificate PDF

On course completion, you will receive a full-sized presentation quality digital certificate.

medtigo Simulation

A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.

medtigo Points

medtigo points is our unique point redemption system created to award users for interacting on our site. These points can be redeemed for special discounts on the medtigo marketplace as well as towards the membership cost itself.
 
  • Registration with medtigo = 10 points
  • 1 visit to medtigo’s website = 1 point
  • Interacting with medtigo posts (through comments/clinical cases etc.) = 5 points
  • Attempting a game = 1 point
  • Community Forum post/reply = 5 points

    *Redemption of points can occur only through the medtigo marketplace, courses, or simulation system. Money will not be credited to your bank account. 10 points = $1.

All Your Certificates in One Place

When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.

Our Certificate Courses